# OnCo record sun-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sun-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sun-pharma" ;
  schema:name "Sun Pharmaceutical Industries"@en ;
  schema:alternateName "DUSA Pharmaceuticals, Inc."@en, "DUSA Pharmaceuticals"@en ;
  schema:description "India's largest drug company, which owns the branded cancer drugs Odomzo and Yonsa in the US and bought the PD-L1 antibody maker Checkpoint Therapeutics in 2025."@en ;
  schema:url <https://onco.cc/companies/sun-pharma/>, <https://sunpharma.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://sunpharma.com> ;
  schema:addressCountry "IN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:drugs <https://onco.cc/drugs/sonidegib/>, <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/cosibelimab/>, <https://onco.cc/drugs/imatinib/> ;
  onco:trials <https://onco.cc/trials/nct05422911/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/> .